cacodylic acid has been researched along with Bladder Cancer in 19 studies
dimethylarsinic acid : The organoarsenic compound that is arsenic acid substituted on the central arsenic atom with two methyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Arsenic exposure is associated with an increased risk of bladder cancer." | 7.75 | Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma. ( Chen, CJ; Chiu, AW; Chung, CJ; Hsueh, YM; Huang, SK; Huang, YK; Pu, YS; Tsai, HJ; Yang, MH, 2009) |
| " We hypothesize that arsenic methylation ability, defined as the ratios of monomethylarsonic acid (MMA(V))/inorganic arsenic (primary arsenic methylation index, PMI) and dimethylarsinic acid (DMA(V))/ MMA(V) (secondary arsenic methylation index, SMI), may modify the association between cumulative arsenic exposure (CAE, mg/L-year) and the risk of bladder cancer." | 7.72 | Arsenic methylation and bladder cancer risk in Taiwan. ( Chen, YC; Christiani, DC; Guo, YL; Hsueh, YM; Lee, MS; Ryan, LM; Smith, TJ; Su, HJ, 2003) |
| "Bladder cancer has been shown to resist programmed cell death with altered expression of both pro-apoptotic and anti-apoptotic proteins." | 5.43 | Diindolylmethane and Lupeol Modulates Apoptosis and Cell Proliferation in N-Butyl-N-(4-Hydroxybutyl) Nitrosamine Initiated and Dimethylarsinic Acid Promoted rat Bladder Carcinogenesis. ( Prabhu, B; Sivakumar, A; Sundaresan, S, 2016) |
| " The present study aimed at comparing the toxic effect of DMMTA(V) with that of inorganic arsenite (iAs(III)) on cell viability, uptake efficiency and production of reactive oxygen species (ROS) toward human bladder cancer EJ-1 cells." | 5.35 | Evidence for toxicity differences between inorganic arsenite and thioarsenicals in human bladder cancer cells. ( Iwata, K; Le, XC; Lee, J; Naranmandura, H; Ogra, Y; Suzuki, KT; Weinfeld, M, 2009) |
| "Arsenic exposure is associated with an increased risk of bladder cancer." | 3.75 | Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma. ( Chen, CJ; Chiu, AW; Chung, CJ; Hsueh, YM; Huang, SK; Huang, YK; Pu, YS; Tsai, HJ; Yang, MH, 2009) |
| "Drinking arsenic-contaminated water is associated with an increased risk of bladder cancer." | 3.74 | Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells. ( Gurr, JR; Jan, KY; Wang, AS; Wang, TC, 2007) |
| " We hypothesize that arsenic methylation ability, defined as the ratios of monomethylarsonic acid (MMA(V))/inorganic arsenic (primary arsenic methylation index, PMI) and dimethylarsinic acid (DMA(V))/ MMA(V) (secondary arsenic methylation index, SMI), may modify the association between cumulative arsenic exposure (CAE, mg/L-year) and the risk of bladder cancer." | 3.72 | Arsenic methylation and bladder cancer risk in Taiwan. ( Chen, YC; Christiani, DC; Guo, YL; Hsueh, YM; Lee, MS; Ryan, LM; Smith, TJ; Su, HJ, 2003) |
| "Bladder cancer has been shown to resist programmed cell death with altered expression of both pro-apoptotic and anti-apoptotic proteins." | 1.43 | Diindolylmethane and Lupeol Modulates Apoptosis and Cell Proliferation in N-Butyl-N-(4-Hydroxybutyl) Nitrosamine Initiated and Dimethylarsinic Acid Promoted rat Bladder Carcinogenesis. ( Prabhu, B; Sivakumar, A; Sundaresan, S, 2016) |
| " The present study aimed at comparing the toxic effect of DMMTA(V) with that of inorganic arsenite (iAs(III)) on cell viability, uptake efficiency and production of reactive oxygen species (ROS) toward human bladder cancer EJ-1 cells." | 1.35 | Evidence for toxicity differences between inorganic arsenite and thioarsenicals in human bladder cancer cells. ( Iwata, K; Le, XC; Lee, J; Naranmandura, H; Ogra, Y; Suzuki, KT; Weinfeld, M, 2009) |
| " Dose-related increases in the height of the thyroid follicular epithelium were also noted in males and females, however, such changes reflect an adaptive response of the thyroid to decreased levels of circulating thyroid hormone, rather than an adverse effect." | 1.33 | Dimethylarsinic acid: results of chronic toxicity/oncogenicity studies in F344 rats and in B6C3F1 mice. ( Arnold, LL; Cohen, SM; Eldan, M; Nyska, A; van Gemert, M, 2006) |
| "From weeks 97-104, urinary bladder tumors were observed in 8 of 31 and 12 of 31 rats in groups treated with 50 and 200 p." | 1.31 | Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. ( Endo, G; Fukushima, S; Iwai, S; Morimura, K; Nakae, D; Wanibuchi, H; Wei, M; Yoshida, K, 2002) |
| "From weeks 97 to 104, urinary bladder tumors were observed in 12 of 31, eight of 31 and none of 33 in groups 1-3, respectively." | 1.30 | Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. ( Fukushima, S; Li, W; Wanibuchi, H; Wei, M; Yamamoto, S, 1999) |
| " Our objectives were to investigate the mode of action of bladder tumor formation, evaluate the dose-response and the role of diet and to determine if the urothelial effects were reversible." | 1.30 | Effects of dietary dimethylarsinic acid on the urine and urothelium of rats. ( Arnold, LL; Cano, M; Cohen, SM; Eldan, M; St John, M; van Gemert, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 10 (52.63) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Sathua, K | 1 |
| Srivastava, S | 1 |
| Flora, SJS | 1 |
| Lin, Z | 1 |
| Shengnan, L | 1 |
| Fei, W | 1 |
| Yingli, S | 1 |
| Qingshan, S | 1 |
| Wei, S | 1 |
| Shuhua, X | 1 |
| Guifan, S | 1 |
| Prabhu, B | 1 |
| Sivakumar, A | 1 |
| Sundaresan, S | 1 |
| Huang, SK | 1 |
| Chiu, AW | 1 |
| Pu, YS | 2 |
| Huang, YK | 3 |
| Chung, CJ | 2 |
| Tsai, HJ | 1 |
| Yang, MH | 2 |
| Chen, CJ | 2 |
| Hsueh, YM | 4 |
| Naranmandura, H | 1 |
| Ogra, Y | 1 |
| Iwata, K | 1 |
| Lee, J | 1 |
| Suzuki, KT | 1 |
| Weinfeld, M | 1 |
| Le, XC | 2 |
| Su, CT | 1 |
| Chen, HW | 1 |
| Shiue, HS | 1 |
| Wei, M | 2 |
| Wanibuchi, H | 5 |
| Morimura, K | 1 |
| Iwai, S | 1 |
| Yoshida, K | 3 |
| Endo, G | 3 |
| Nakae, D | 1 |
| Fukushima, S | 6 |
| Chen, YC | 1 |
| Su, HJ | 1 |
| Guo, YL | 1 |
| Smith, TJ | 1 |
| Ryan, LM | 1 |
| Lee, MS | 1 |
| Christiani, DC | 1 |
| Arnold, LL | 3 |
| Eldan, M | 2 |
| Nyska, A | 1 |
| van Gemert, M | 2 |
| Cohen, SM | 3 |
| Ohnishi, T | 1 |
| Wang, TC | 1 |
| Jan, KY | 1 |
| Wang, AS | 1 |
| Gurr, JR | 1 |
| Clewell, HJ | 1 |
| Thomas, RS | 1 |
| Gentry, PR | 1 |
| Crump, KS | 1 |
| Kenyon, EM | 1 |
| El-Masri, HA | 1 |
| Yager, JW | 1 |
| Huang, YL | 1 |
| Wu, MM | 1 |
| Chen, SY | 1 |
| Hsu, LI | 1 |
| Yamamoto, S | 4 |
| Chen, H | 1 |
| Hori, T | 1 |
| Li, W | 2 |
| Salim, EI | 1 |
| Chen, T | 1 |
| Na, Y | 1 |
| Lee, CC | 1 |
| Cano, M | 1 |
| St John, M | 1 |
1 review available for cacodylic acid and Bladder Cancer
| Article | Year |
|---|---|
Arsenic-induced bladder cancer in an animal model.
Topics: Animals; Arsenic; Arsenicals; Cacodylic Acid; Carcinogens; Disease Models, Animal; Hemoglobins; Mice | 2007 |
18 other studies available for cacodylic acid and Bladder Cancer
| Article | Year |
|---|---|
MiADMSA ameliorate arsenic induced urinary bladder carcinogenesis in vivo and in vitro.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anticarcinogenic Agents; Arsenites; Cacodylic Acid; Carcinoma, | 2020 |
Dimethylarsinic acid (DMA(V) ) changed the expressions of proliferative related factors and secretion of inflammatory cytokines in rat bladder.
Topics: Animals; Cacodylic Acid; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; Cytokines; Enzyme-Linked I | 2015 |
Diindolylmethane and Lupeol Modulates Apoptosis and Cell Proliferation in N-Butyl-N-(4-Hydroxybutyl) Nitrosamine Initiated and Dimethylarsinic Acid Promoted rat Bladder Carcinogenesis.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Butylhydroxybutylnitrosamine; Cacodylic Acid; Carcin | 2016 |
Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Arsenicals; Arylsulfotransferase; Cacodylic Acid; Carcinoma; Chromat | 2009 |
Evidence for toxicity differences between inorganic arsenite and thioarsenicals in human bladder cancer cells.
Topics: Aquaporins; Arsenic Poisoning; Arsenicals; Arsenites; Cacodylic Acid; Carcinogenicity Tests; Carcino | 2009 |
Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Arsenic; Cacodylic Acid; Carcinoma, | 2010 |
Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; beta Catenin; Cacodylic Acid; Carcinogens; Cytoskeletal Protei | 2002 |
Arsenic methylation and bladder cancer risk in Taiwan.
Topics: Aged; Arsenicals; Cacodylic Acid; Carcinoma, Transitional Cell; Case-Control Studies; Female; Humans | 2003 |
Dimethylarsinic acid: results of chronic toxicity/oncogenicity studies in F344 rats and in B6C3F1 mice.
Topics: Administration, Oral; Animals; Cacodylic Acid; Carcinogens; Dose-Response Relationship, Drug; Female | 2006 |
Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells.
Topics: Arsenic Poisoning; Arsenicals; Cacodylic Acid; Cell Line; DNA Damage; Glutathione; Humans; Lipid Per | 2007 |
Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
Topics: Animals; Arsenic; Arsenicals; Cacodylic Acid; Carcinogens; Cell Proliferation; DNA; DNA Repair; Dose | 2007 |
Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
Topics: Adult; Aged; Arsenic; Arsenic Poisoning; Arsenicals; Cacodylic Acid; Carcinoma, Transitional Cell; C | 2008 |
Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats.
Topics: Animals; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Cacodylic Acid; Carcinogens; Cell Division | 1996 |
Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound.
Topics: Alpha-Globulins; Animals; Butylhydroxybutylnitrosamine; Cacodylic Acid; Carcinogenicity Tests; DNA, | 1998 |
Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats.
Topics: Administration, Oral; Animals; Cacodylic Acid; Carcinogenicity Tests; Carcinoma, Transitional Cell; | 1999 |
Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
Topics: Animals; Ascorbic Acid; Butylhydroxybutylnitrosamine; Cacodylic Acid; Carcinogenicity Tests; Carcino | 1999 |
Effects of dietary dimethylarsinic acid on the urine and urothelium of rats.
Topics: Animals; Body Weight; Bromodeoxyuridine; Cacodylic Acid; Diet; Drinking Behavior; Feeding Behavior; | 1999 |
Possible involvement of O6-methylguanine formation and p53 dysfunction in mouse urinary bladder carcinogenesis.
Topics: Animals; Butylhydroxybutylnitrosamine; Cacodylic Acid; Carcinogens; Cell Division; Cell Transformati | 2001 |